Inventor · disambiguated record
Nicholas Moore
Also filed as: MOORE NICHOLAS · MOORE NICHOLAS A · MOORE NICHOLAS ALLEN
8 granted patents·5 pending applications·53 citations·filing 2007–2024
85Inventor score
Top patents by PatentIndex Score
13 records- 0194US8722684B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentBANG-ANDERSEN BENNY·Filed 2007·Granted May 13, 2014·31 cites·8 claims
- 0287US11684618B2Compositions comprising mixtures of compounds and uses thereofPROSTASIS LLC·Filed 2022·Granted Jun 27, 2023·4 cites·18 claims
- 0384US9511018B2Clonidine compounds in a biodegradable matrixCLAY DANIELLE L·Filed 2012·Granted Dec 6, 2016·5 cites·20 claims
- 0481US11628166B2Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1a activityH LUNDBECK AS·Filed 2020·Granted Apr 18, 2023·1 cites·9 claims
- 0579US9211274B2TRPV1 compounds in a biodegradable polymer carrierMOORE NICHOLAS A·Filed 2012·Granted Dec 15, 2015·3 cites·11 claims
- 0678US8664225B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognitionMOORE NICHOLAS·Filed 2008·Granted Mar 4, 2014·7 cites·5 claims
- 0778US2024082239A1Therapeutic Uses of Compounds Having Combined Sert, 5-HT3 and 5-HT1a ActivityH LUNDBECK AS·Filed 2023·Application pending·0 cites
- 0877US9744166B2Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activityH LUNDBECK AS·Filed 2016·Granted Aug 29, 2017·2 cites·9 claims
- 0973US2025099452A1Compositions comprising mixtures of compounds and uses thereofPROSTASIS LLC·Filed 2024·Application pending·0 cites
- 1070US12201624B2Compositions comprising mixtures of compounds and uses thereofPROSTASIS LLC·Filed 2023·Granted Jan 21, 2025·0 cites·22 claims
- 1159US2016083359A11-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENTLUNDBECK & CO AS H·Filed 2015·Application pending·0 cites
- 1256US2018161321A1Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A ActivityH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1351US2016095829A1Trpv1 compounds in a biodegradable polymer carrierWARSAW ORTHOPEDIC INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Moore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →